180 related articles for article (PubMed ID: 27446807)
1. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
Aanei CM; Picot T; Tavernier E; Guyotat D; Campos Catafal L
Front Oncol; 2016; 6():161. PubMed ID: 27446807
[TBL] [Abstract][Full Text] [Related]
2. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
Lu D; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia.
Muyldermans A; Florin L; Devos H; Cauwelier B; Emmerechts J
Hematology; 2019 Dec; 24(1):166-172. PubMed ID: 30334700
[TBL] [Abstract][Full Text] [Related]
5. Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.
Kern W; Westers TM; Bellos F; Bene MC; Bettelheim P; Brodersen LE; Burbury K; Chu SC; Cullen M; Porta MD; Dunlop AS; Johansson U; Matarraz S; Oelschlaegel U; Ogata K; Porwit A; Preijers F; Psarra K; Saft L; Subirá D; Weiß E; van der Velden VHJ; van de Loosdrecht A
Cytometry B Clin Cytom; 2023 Jan; 104(1):51-65. PubMed ID: 36416672
[TBL] [Abstract][Full Text] [Related]
6. [Value of multiparameter flow cytometry in the diagnosis and prognostic evaluation of childhood myelodysplastic syndrome].
Liu C; An WB; Zhang JL; Zhang RR; Sun CC; Chang LX; Liu TF; Zou Y; Wang HJ; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Oct; 20(10):819-824. PubMed ID: 30369356
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry "Ogata score" for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience.
Grille Montauban S; Hernandez-Perez CR; Velloso EDRP; Novoa V; Lorand-Metze I; Gonzalez J; Solari L; Cismondi V; Serrano JC; Burgnini A; Rabelo-Carrasco LJ; Bacal N; Trias N; Guevara R; Rico Vido J; Crisp R; Enrico A; Boada M; Pereira Cunha FG; Fanessi V; Venegas MB; Issouribehere D; Novoa A; Lens D
Int J Lab Hematol; 2019 Aug; 41(4):536-541. PubMed ID: 31066993
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India.
Dhingra G; Dass J; Arya V; Gupta N; Saraf A; Langer S; Aggarwal S; Kotwal J; Bhargava M
Indian J Med Res; 2020 Sep; 152(3):254-262. PubMed ID: 33107485
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data.
Kern W; Haferlach C; Schnittger S; Haferlach T
Cancer; 2010 Oct; 116(19):4549-63. PubMed ID: 20572043
[TBL] [Abstract][Full Text] [Related]
10. Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients.
Kern W; Bacher U; Haferlach C; Alpermann T; Schnittger S; Haferlach T
Cytometry B Clin Cytom; 2015; 88(3):154-64. PubMed ID: 25581461
[TBL] [Abstract][Full Text] [Related]
11. Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile.
Guarnera L; Fabiani E; Attrotto C; Hajrullaj H; Cristiano A; Latagliata R; Fenu S; Buccisano F; Irno-Consalvo M; Conti C; Voso MT; Maurillo L
Ann Hematol; 2023 Nov; 102(11):3015-3023. PubMed ID: 37535147
[TBL] [Abstract][Full Text] [Related]
12. Implementation of the Ogata flow cytometric scoring system in routine diagnostics of myelodysplastic syndrome.
Matzen SMH; Raaschou-Jensen KK; Kallenbach K
Health Sci Rep; 2018 Nov; 1(11):e90. PubMed ID: 30623045
[TBL] [Abstract][Full Text] [Related]
13. The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review.
Bento LC; Correia RP; Pitangueiras Mangueira CL; De Souza Barroso R; Rocha FA; Bacal NS; Marti LC
Front Oncol; 2017; 7():270. PubMed ID: 29188193
[TBL] [Abstract][Full Text] [Related]
14. Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact.
Oelschlaegel U; Oelschlaeger L; von Bonin M; Kramer M; Sockel K; Mohr B; Wagenfuehr L; Kroschinsky F; Bornhaeuser M; Platzbecker U
Cytometry B Clin Cytom; 2023 Mar; 104(2):141-150. PubMed ID: 34390327
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry in the diagnosis of myelodysplastic syndromes and the value of myeloid nuclear differentiation antigen.
Bellos F; Kern W
Cytometry B Clin Cytom; 2017 May; 92(3):200-206. PubMed ID: 26184452
[TBL] [Abstract][Full Text] [Related]
16. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.
Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
Cytometry B Clin Cytom; 2015 Mar; 88(2):125-35. PubMed ID: 25490867
[TBL] [Abstract][Full Text] [Related]
17. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
Davydova YO; Parovichnikova EN; Galtseva IV; Kokhno AV; Dvirnyk VN; Kovrigina AM; Obukhova TN; Kapranov NM; Nikiforova KA; Glinkina SA; Troitskaya VV; Mikhailova EA; Fidarova ZT; Moiseeva TN; Lukina EA; Tsvetaeva NV; Nikulina OF; Kuzmina LA; Savchenko VG
Cytometry B Clin Cytom; 2021 May; 100(3):312-321. PubMed ID: 33052634
[TBL] [Abstract][Full Text] [Related]
19. Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms.
Chen X; Johansson U; Cherian S
Clin Lab Med; 2023 Dec; 43(4):521-547. PubMed ID: 37865501
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single-centre real-life experience.
Majcherek M; Kiernicka-Parulska J; Mierzwa A; Barańska M; Matuszak M; Lewandowski K; Komarnicki M; Czyż A
Scand J Immunol; 2021 Aug; 94(2):e13028. PubMed ID: 33577137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
